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http://dx.doi.org/10.1016/j.stemcr.2016.05.012SUMMARYMetabolism is remodeled when somatic cells are reprogrammed into induced pluripotent stem cells (iPSCs), but themajority of iPSCs are
not fully reprogrammed. In a shift essential for reprogramming, iPSCs use less mitochondrial respiration but increased anaerobic glycol-
ysis for bioenergetics.We found thatmicroRNA 31 (miR-31) suppressed succinate dehydrogenase complex subunit A (SDHA) expression,
vital formitochondrial electron transport chain (ETC) complex II.MiR-31 overexpression in partially reprogrammed iPSCs lowered SDHA
expression levels and oxygen consumption rates to that of fully reprogrammed iPSCs, but did not increase the proportion of fully reprog-
rammed TRA1-60+ cells in colonies unless miR-31 was co-transduced with Yamanaka factors, which resulted in a 2.7-fold increase in full
reprogramming. Thus switching frommitochondrial respiration to glycolyticmetabolism through regulation of themiR-31/SDHA axis is
critical for lowering the reprogramming threshold. This is supportive of multi-stage reprogramming whereby metabolic remodeling is
fundamental.INTRODUCTION
The majority of induced pluripotent stem cells (iPSCs) are
not fully reprogrammed (Chan et al., 2009; Lee et al.,
2013; Mikkelsen et al., 2008). There is still minimal infor-
mation on transition checkpoints necessary to induce full
reprogramming. Pluripotent stem cells (PSCs) have func-
tions and requirements different from somatic cells. In
contrast to somatic cells, PSCs have a shorter G1 phase of
the cell cycle and unlimited cell growth capacity, as in can-
cer stem cells (CSCs). While PSCs have metabolic activities
very different from those of somatic cells to meet a proper
balance between ATP production as an energy source and
biosynthetic demands (Varum et al., 2011; Zhang et al.,
2012), metabolic differences between partial (par) and fully
(full) reprogrammed iPSCs are yet to be determined.
Increased glycolytic flux is characteristic of CSCs and em-
bryonic stem cells (ESCs). They require increased ATP and
anabolic precursors for rapid proliferation compared with
normal somatic cells (Zhang et al., 2012). Metabolism of
ESCs differs from CSCs; they contain lower numbers of
mitochondria and less mtDNA (Folmes et al., 2012), and
have less active oxidative phosphorylation (Folmes et al.,
2011). ESCs are particularly vulnerable to oxygen radicals,
which cause genomic damage, apoptosis, and decreased
differentiation capacity (Han et al., 2008; Zhang et al.,
2012). This is important for lower mitochondrial respira-
tion in PSCs, because reactive oxygen species (ROS) gener-
ation is a consequence of electron transport chain (ETC)
activity. Shifting to anaerobic glycolysis is a formof ROS de-This is an open access article under the Cfense. Somatic cells must switch mitochondrial oxidative
metabolism to anaerobic glycolytic pathways during iPSC
reprogramming (Folmes et al., 2011; Liu et al., 2013; Xu
et al., 2013). However, little is known regarding molecular
mechanisms involved in metabolic reprogramming.
We reported that CD34+ cells from thawed human cord
blood (CB) cryopreserved for more than 20 years could be
successfully reprogrammed using lentiviruses expressing
Yamanaka factors (Broxmeyer et al., 2011). Here, we identi-
fied partially reprogrammed cells by cell-surface expression
of TRA-1-60, a bona fide marker of fully reprogrammed
cells (Chan et al., 2009). Twelve days after CD34+ cells
were transduced with Yamanaka factors, about 5% of total
colonies expressed TRA1-60. These colonies represented
fully reprogrammed cells (Lee et al., 2013). We also
observed TRA1-60-negative colonies, with morphology
similar to that of human ESCs (hESCs) but representing
partially reprogrammed cells. We suggested that partially
reprogrammed cells are ‘‘trapped’’ in an incompletely re-
programmed yet stable state not sufficient for full reprog-
ramming (Chan et al., 2009; Lee et al., 2013).
We hypothesized that shifts in mitochondrial metabolic
pathway checkpoints might be central to early stages of
reprogramming prior to full pluripotency induction. Evi-
dence for this exists (Folmes et al., 2011; Panopoulos
et al., 2012; Xu et al., 2013), but detailed molecular mech-
anisms are lacking. MicroRNAs (miRNAs) regulate bio-
logical processes including embryonic development and
somatic cell reprogramming (Anokye-Danso et al., 2011;
Bang and Carpenter, 2008; Bartel, 2004). Among miRNAsStem Cell Reports j Vol. 7 j 1–10 j July 12, 2016 j ª 2016 The Authors. 1
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upregulated in fully reprogrammed iPSCs (Lee et al., 2013),
we focused on miRNA 31 (miR-31), which is involved in
cell proliferation (Slaby et al., 2007), migration (Valastyan
et al., 2009), apoptosis (Bhatnagar et al., 2010), and differ-
entiation (Deng et al., 2013). We postulated a role for miR-
31 in metabolic transition to fully programmed iPSCs (full-
iPSCs). Using bioinformatics, luciferase reporter assays, and
overexpression experiments, a highly conserved binding
site for miR-31 was predicted in the 30 UTR of succinate de-
hydrogenase (succinate dehydrogenase complex subunit
A; SDHA), which is part of the mitochondrial respiratory
chain complex II and is encoded by nuclear DNA (Grimm,
2013), and participates in electron transfer in the respira-
tory chain and succinate catabolism in the Krebs cycle
(Kim et al., 2012). Mutations in SDHA are rare but are
linked to severe metabolic disorders resulting from
decreased Krebs cycle activity, impaired oxidative phos-
phorylation, and bioenergetic deficiency. In contrast to
other SDHs, inhibition of SDHA does not increase produc-
tion of ROS under conditions of normal O2 tension (nor-
moxia), suggesting that reduction of SDHA activity might
be an ideal way to reduce mitochondrial ETC activity,
thus promoting fulliPSC induction while maintaining
low ROS generation (Guzy et al., 2008). Evaluating meta-
bolism of iPSCs without dissecting fully from partially re-
programmed iPSCs (pariPSCs), where the partially reprog-
rammed cells represent a majority of iPSCs, does not
allow accurate evaluation of regulation of fulliPSC meta-
bolism. We identified an miR-31/SDHA axis involvement
in conversion of somatic cells to fulliPSCs, delineating a
previously unrecognized role for miR-31 in regulating
mitochondrial metabolism through suppressing SDHA
during reprogramming. This may serve as a stratagem to
more efficiently generate fulliPSCs for potential therapeu-
tic use.RESULTS
PariPSC Mitochondria Are Distinct from Those in
FulliPSCs
PariPSCs are trapped in a stable intermediate reprogram-
ming state (Chan et al., 2009; Mikkelsen et al., 2008).
Although additional stem cell-related gene regulation is
required to somehow overcome this barrier for transition
to pluripotency (Mikkelsen et al., 2008), fulliPSCs and par-
iPSCs have not beenwell characterized formetabolic differ-
ences. We have now evaluated this for mitochondrial dy-
namics and respiration/oxygen consumption rates (OCR).
Although there are no distinct differences in colony
morphology between fully and partially reprogrammed
cells (Figure 1A), all cells within fulliPSC colonies exhibited
endogenous expression of OCT4, NANOG, SSEA4, and2 Stem Cell Reports j Vol. 7 j 1–10 j July 12, 2016TRA-1-60 at levels similar to those of hESCs (Figure 1B, up-
per panel). Few cells within pariPSC colonies expressed
these proteins (Figure 1B, lower panel).
We separately cultured and characterized pariPSCs and
fulliPSCs using live TRA1-60 cell staining (Lee et al.,
2013). pariPSCs (GFP/TRA1-60) had suppressed endoge-
nous pluripotency gene expression as well as exogenous
pluripotent gene expression (Figure S1A). Total and mito-
chondria-linked portions of total basal OCR, using a Sea-
horse Extracellular Flux analyzer, was greater in pariPSCs
than in fulliPSCs, as was ATP-linked OCR, suggesting that
pariPSCs aremore dependent onmitochondrial respiration
for their bioenergetic needs than fulliPSCs (Figure 1C).
Treatment with the protonophore FCCP (carbonylcyanide
p-trifluoromethoxyphenylhydrazone) had little effect on
OCR in pariPSCs and fulliPSCs, consistent with ESCs hav-
ing more ‘‘uncoupled’’ ETC than early differentiated
ESCs, potentially due to increased uncoupling of protein-
2 expression (Zhang et al., 2011); i.e., OXPHOS is more un-
coupled from electron transport through the ETC and its
subsequent translocation of protons and generation of
proton motive force. Lower mitochondrial respiration in
fulliPSCs could also be due to developmental immaturity
of mitochondria. Structural/morphological changes in
mitochondria, as well as function, are thought to be an ab-
solute requirement for somatic cell reprogramming to
iPSCs (Folmes et al., 2012; Xu et al., 2013). Using electron
microscopy, the majority of mitochondria in fulliPSCs
were rounded to oval, while those of pariPSCs were more
elongated and enlarged with more defined cristae (Fig-
ure 1D), demonstrating that mitochondria in fulliPSCs
are more immature in appearance than in pariPSCs. full-
iPSCs had lower mitochondrial mass and decreased mito-
chondrial membrane potential compared with pariPSCs,
and pariPSCs had elevated ROS levels (Figures 1E and 1F).
This indicates preference for mitochondrial respiration in
pariPSCs to support their bioenergetic needs.
PariPSCs and FulliPSCs Display Distinct
Mitochondrial Gene and miRNA Profiles
FulliPSCs have a very different mitochondrial phenotype
from pariPSCs, which could account for the higher mito-
chondrial respiration of pariPSCs.We examinedmitochon-
drial gene-expression microarrays and found that a major-
ity of genes coding for components of mitochondrial
complex II and IV are more highly expressed in pariPSCs
(Figure 2A and Table S1). SDHA was expressed at very
low levels in human ESCs (hESC-H9), iPSCs (CB fulliPSC
and fibro-fulliPSC), and embryonic carcinoma cells
(ECCs; hECC-NT2), but was significantly increased in
differentiated somatic cells (CB), pariPSCs (CB-partial cell
and fibro-partial cell), and hESC-derived embryoid bodies
(hESC-EB) especially when compared with the relative
Figure 1. Differential Mitochondrial Characteristics in Partially Compared with Fully Reprogrammed iPSCs
(A) Microscope images of pariPSCs and fulliPSCs. Scale bars, 200 mm.
(B) Expression of exogenous GFP (green) and hESC-specific marker genes (red) OCT4, NANOG, SSEA4, and TRA1-60 in iPSCs by immuno-
fluorescence analyses. Nuclei were counterstained with DAPI (blue). Scale bars, 100 mm.
(C) Average OCR measured before and after the indicated treatments. Mean basal OCR ± SD is the average of three independent experi-
ments. Student’s t test: *p < 0.05.
(D) Electron micrographs of mitochondria in pariPSCs and fulliPSCs. Arrows indicate mitochondria. Scale bars, 500 nm.
(E) Quantitative analysis comparing mitochondrial membrane potential by JC-1 and mitochondrial mass by Mitotracker Green FM staining
in hESCs, and fulliPSCs and pariPSCs. The results represent the mean ± SD of four independent experiments performed in triplicate.
Student’s t test: *p < 0.05.
(F) Intracellular ROS quantitation in fulliPSCs and pariPSCs stained with Mitotracker Orange and assessed by flow cytometry. The results
represent the mean ± SD of four independent experiments performed in triplicate. Student’s t test: *p < 0.05.expression abundance of the mitochondrial gene, COX-4,
as well as with cytosolic b-actin (Figure 2B). We found
that OCT4 and SDHA are mutually exclusive in pariPSCs
and fulliPSCs.
This questions how mitochondrial gene changes occur
during reprogramming. Understanding molecular mecha-
nisms responsible for this blockage could aid in improvingreprogramming efficiency. Metabolic remodeling occurs
early in reprogramming (Figure 2) (Hansson et al., 2012;
Varum et al., 2011); blocks to complete reprogramming
in pariPSCs could involve further modification of mito-
chondrial characteristics needed for progression to full-
iPSCs. We hypothesized that miRNAs play an important
role in differential mitochondrial characteristics, andStem Cell Reports j Vol. 7 j 1–10 j July 12, 2016 3
Figure 2. Differential Mitochondrial Gene
and miRNA Profiles
(A) Scatterplot compares normalized expres-
sion of mitochondria-related genes by plot-
ting pariPSCs against fulliPSCs. The green
dots indicate mitochondrial genes with R5-
fold decrease in the relative expression in
pariPSC compared with fulliPSC. The red dots
indicate genes with R5-fold increase in the
relative expression in pariPSC compared with
fulliPSC. Lower panel shows list of genes
whose expression changes >5-fold.
(B) Expression levels of proteins in CB cells,
hESCs, fulliPSCs, pariPSCs, and hECCs assessed
by western blotting.
(C) Scatterplot of miRNA PCR array. The green
dots indicate miRNSs with R5-fold decrease
in the relative expression in pariPSC com-
pared with fulliPSC. The red dots indicate
genes with R5-fold increase in the relative
expression in pariPSC compared with fulliPSC.
Lower panel shows list of miRNAs with high
and low expression in pariPSCs.
(D) Individual PCR reactions normalized
against U6 and plotted relative to expression
level in CB cells. The results represent the
mean ± SD of four independent experiments
performed in triplicate. Student’s t test: *p <
0.05 and **p < 0.01.carried out miRNA PCR-array analysis (Lee et al., 2013).
pariPSCsweremarkedly different from fulliPSCs inmiRNA
expression profiles (Figure 2C). To narrow the list of
putative miRNAs that can regulate highly expressed genes
in pariPSCs, we analyzed in silico algorithms using
TargetScan (ver.5.1). We further restricted putative targets
to those potentially associated with downregulated mito-
chondrial-specific genes in fulliPSCs. We focused on
miR-31 andmiR-141 from a list of low-expressionmiRNAs
in pariPSCs that have the potential to bind SDHA, COX8,
and ATP6V1C2, a vacuolar-type H+-ATPase (V-ATPase) C2
subunit gene. fulliPSCs expressed much higher levels of
miR-31 and miR-141 than pariPSCs (Figure 2D). We hy-
pothesized that these candidate miRNAs might be
involved in overcoming a conversion barrier from par-
iPSCs to fulliPSCs via regulation of mitochondrial meta-
bolism by suppressing mitochondrial gene expression
and activity.4 Stem Cell Reports j Vol. 7 j 1–10 j July 12, 2016SDHA, a Bona Fide Direct Target of miR-31
To identify bona fide miRNA targets among those pre-
dicted, we generated wild-type 30 UTR (WT) and mutated
30 UTR (Mut) Renilla luciferase reporter constructs (psi-
check-2). SDHA containing Renilla luciferase activity
was significantly downregulated compared with control
(Figure 3A). In contrast, activities were not altered in
the presence of COX8 and ATP6V1C-containing con-
structs, which were predicated as miR-141 putative tar-
gets. Together with bioinformatics predictions, downre-
gulation of luciferase activity of SDHA by miR-31, and
protein expression levels of SDHA (Figure 2B), this
demonstrated that miR-31 represses gene expression by
recognizing the predicted target sequence in the 30 UTR
of SDHA.
To determine whether downregulation of SDHA in par-
iPSCs could be due to miR-31, we overexpressed miR-31
in pariPSCs. We confirmed the expression level of miR-31
Figure 3. SDHA Is a Bona Fide Direct Target of miR-31
(A) Vector alone (control) or luciferase reporter constructs containing WT 30 UTR of SDHA, ATPase6, or COX8 (WT) or mutant 30 UTR (Mut)
were co-transfected in the presence of miRNA oligomers to hECCs. Effects of miR-31 and miR-141 on relative luciferase activities are
presented as histograms. The histogram represents the mean ± SD of three independent experiments performed in triplicate. Student’s
t test: *p < 0.05.
(B) Expression of SDHA with miR-31 is shown in upper panels (immunostaining) and western blotting in the lower panel. The bar
chart presents relative fluorescence intensity of SDHA and represents the mean ± SD of three independent experiments. Student’s t test:
**p < 0.01.in pariPSC transduced with lentiviral construct with miR-
31 gene by qPCR (Figure S1B). Using confocal microscopy,
pariPSCs transduced with a scramble control construct
showed widespread punctate expression of SDHA, whereas
miR-31-overexpressing cells had reduced SDHA expression
(Figure 3B). pariPSCs transduced with miR-31 had signifi-
cantly decreased SDHA protein expression by western
blot (Figure 3B, bottompanel). This level inmiR-31-overex-
pressing cells was similar to that in fulliPSCs. Thus, down-
regulated miR-31 expression results in increased SDHA
expression in pariPSCs.MiR-31 Overexpression Modulates Metabolic
Functions by Suppressing SDHA Activity
To ensure a functional connection with miR-31 and SDHA
complex II enzyme activity, we transduced miR-31 or short
hairpin RNA (shRNA)-SDHA into human CB-CD34+ cells
and measured in vitro enzyme activity of ETC complex II
SDHA in pariPSCs overexpressing miR-31 (Figures 4A,
S2A, and S2B). Complex II activity in pariPSCs overexpress-
ing miR-31 was reduced 45.3% compared with fulliPSCs.
Inhibition of SDHA by shRNA also decreased complex II ac-
tivity by greater than 56.1% (Figure 4A). Thus, miR-31Stem Cell Reports j Vol. 7 j 1–10 j July 12, 2016 5
Figure 4. MiR-31 and shRNA-SDHA Increase Complete Reprogramming
(A) ETC complex II activity assays showing miR-31 and shRNA-SDHA represses complex II activity by approximately 50%. y Axis represents
rate, which is the difference in the absorbance divided by time and normalized to total protein. The results represent the mean ± SD of
three independent experiments performed in triplicate. Student’s t test: *p < 0.05 and **p < 0.01.
(B) Basal OCR measured by respirometry. The results represent the mean ± SD of three independent experiments performed in triplicate.
Student’s t test: **p < 0.01.
(C) Relative mitochondrial membrane potential and percentage of cells with high membrane potential, andmitochondrial mass. The results
represent the mean ± SD of three independent experiments performed in triplicate. Student’s t test: *p < 0.05 and **p < 0.01.
(D) Relative mitochondrial ROS levels. The results represent the mean ± SD of three independent experiments performed in triplicate.
Student’s t test: **p < 0.01.
(E) Electron microscopy of mitochondria in miR-31 and shRNA-SDHA pariPSCs. Scale bars, 500 nm.
(F) miR-31 and shRNA-SDHA pariPSCs (left panel) or CB-CD34+ cells with Yamanaka factors (right panel) analyzed by fluorescence-acti-
vated cell sorting for expression of TRA-1-60. The results represent the mean ± SD of three independent experiments for each miR-31 and
shRNA transduction performed in triplicate. Student’s t test: *p < 0.05.
(G) Karyotyping analysis in fully reprogrammed iPSCs generated by co-infection OE-miR-31 and KD-SDHA with Yamanaka factor in CB-
CD34+ cells revealed normal chromosomal stability.
(H) Teratomas derived from immunodeficient mice injected with fully reprogrammed iPSCs generated by co-infection OE-miR-31 and KD-
SDHA with Yamanaka factor in CB-CD34+ cells miR-302-iPS cells show tissues representing all three embryonic germ layers, including
respiratory tract (endoderm), cartilage (mesoderm), and secretory epithelium or neural rosette (ectoderm). Scale bars, 50 mm.
(I) Proposed mechanism showing that miR-31/SDHA axis acts as a master switch for pluripotent metabolic reprogramming.
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suppresses mitochondrial complex II activity via suppres-
sion of SDHA transcription.
We measured mitochondrial respiration in lentiviral
miR-31 overexpression or shRNA-SDHA-treated pariPSCs
to explore a link between miR-31 and activity of the
SDHA complex II enzyme in regulating metabolism. Both
shRNA-SDHA and lentiviral miR-31 led to a reduction of
basal OCR of 62% and 72%, respectively, similar to levels
in fulliPSCs (Figure 4B). ShRNA-SHDA and overexpressed
miR-31 reduced mitochondrial membrane potential,
mitochondrial mass, and ROS levels (Figures 4C and 4D).
Mitochondrial membrane potential and ROS production,
assayed by JC-9 and DCF-DA, respectively, displayed
similar patterns (Figure S3A). To further define pariPSCs
we assessed the levels of succinate and fumarate, mito-
chondrial substrates produced by Krebs cycle reaction (Fig-
ure S3B). Partially reprogrammed cells significantly accu-
mulated levels of succinate similar to those from fully
reprogrammed cells. Overexpression of miR-31 or shRNA-
SDHA into pariPSC increased succinate levels almost to
levels of fulliPSCs, indicating that miR31 promotes reprog-
ramming by attenuating mitochondrial complex II func-
tion. Reduced ROS generation is consistent with dimin-
ished mitochondrial ETC activity and is a critical factor in
maintaining pluripotency (Han et al., 2008). Compared
with mitochondrial morphology of pariPSCs, the mor-
phology of lentiviral miR-31 or shRNA-SDHA-treated par-
iPSCs was a more immature round shape, consistent with
mitochondria found in PSCs and non-transduced fulliPSCs
(Figure 4E). This indicates that the miR-31-SDHA axis
might also be correlatedwithmitochondrial biogenesis/dy-
namics as well as the reprogramming process.
Early Overexpression of MiR-31 or shRNA-SDHA Is
Required for Full Reprogramming
We investigated when transduction of miR-31 and shRNA-
SDHA was required for maximal Tra1-60 induction. We
transduced miR-31 or shRNA-SDHA into CD34+ starting
cells and into pariPSCs and compared expression levels of
TRA1-60, a marker for fulliPSC (Figure 4F). CB-CD34+ cells
transduced with lentiviral miR-31 induced TRA1-60 by 2.7-
fold compared with control cells (Figure 4F, right panel),
while transduced, pariPSCs did not show increased expres-
sion of TRA1-60 (Figure 4F, left panel). Effects of transduced
shRNA-SDHA on TRA1-60 induction was observed only in
CD34+ cells but not in pariPSCs after reprogramming cul-
ture, indicating that miR-31 or shRNA-SDHA exerted
maximal effects only when introduced to the cells at an
early stage of reprogramming. Reprogramming proceeds
through a series of stages, but the majority of cells are trap-
ped by transition barriers, generating intermediate cells as a
transition state during reprogramming. Downmodulation
of SDHA may be necessary to lower the threshold of suchbarriers to improve reprogramming efficiency before cells
undertake remodeling of epigenetic marks, such as DNA
methylation, for transition to a fulliPSC stage.
Karyotype assay indicated no sign of chromosomal ab-
normality in iPSCs derived from cells transduced with
miR-31 or shRNA-SDHA (Figure 4G). TRA1-60+ cells
derived from CB-CD34+ cells overexpressing miR-31 or
shRNA-SDHA developed teratomas containing three
germ-cell layers, a trait of iPSCs and PSCs (Figure 4H).
Thus, upregulation of miR-31 improves reprogramming ef-
ficiency without altering prototype iPSC characteristics.
We have demonstrated that miR-31 may play an impor-
tant role in improving reprogramming efficiency by
lowering thresholds of transition stages, likely by remodel-
ing mitochondria through SHDA, a critical enzyme for
mitochondrial functions, acting at early stages of the re-
programming process.DISCUSSION
Yamanaka factors induce somatic cell reprogramming to
iPSCs by promoting spatiotemporal expression of PSC-spe-
cific andmetabolic genes. However, only a small fraction of
these cells complete full reprogramming, leavingmost cells
at an intermediate stage (Chan et al., 2009; Lee et al., 2013;
Mikkelsen et al., 2008), suggesting that cells remaining at
an intermediate stage may be restricted by a ‘‘reprogram-
ming checkpoint.’’ Mitochondrial reprogramming may be
coupled with cell-fate conversion (Buganim et al., 2013;
Hansson et al., 2012). We termed these intermediate cells
collectively as pariPSCs, with distinguishing characteris-
tics. (1) Unlike somatic cells, pariPSCs formed colonies
similar to those of fully reprogrammed cells (Figures 1A
and 1B). (2) However, pariPSCs differed from fulliPSCs in
mitochondrial functions. (3) pariPSCs did not express
pluripotent-specific genes such as TRA1-60, or endogenous
OCT4 and SOX2, which are abundantly expressed in full-
iPSCs (Figure 1B). (4) pariPSCs resembled fulliPSCs with re-
gard to self-renewal potential, as they multiplied up to at
least 20 passages without losing their phenotypes. (5) How-
ever, pariPSCs were not simply transformed cells sporadi-
cally generated during reprogramming, as manifested by
their inability to form teratomas in vivo when implanted
into mice (Lee et al., 2013). (6) Unlike somatic cells, par-
iPSCs studied here possessed the same feature as fulliPSCs
in the ability to silence exogenously transduced genes. Tak-
ing all of these unique characteristics of these cells into
consideration, we referred to TRA1-60 and GFP cells as
pariPSCs.
Molecular mechanisms involved in reprogramming so-
matic cells to fulliPSC by Yamanaka factors remain largely
enigmatic, particularly with respect to the mitochondrialStem Cell Reports j Vol. 7 j 1–10 j July 12, 2016 7
metabolic shift from respiration-dependent bioenergetic to
more glycolytic pathways. PariPSCs and fulliPSCs were
quite different in expression levels of miR-31 and SDHA,
a flavoprotein subunit of mitochondria complex II and vi-
tal for the Krebs cycle. MiR-31 was expressed in pariPSCs
and somatic cells at minimal levels, but was expressed
abundantly in fulliPSCs and PSCs. Opposite to miR-31,
SDHA was found in pariPSCs and somatic cells at high
levels, but at low levels in fulliPSCs and ESCs. Reciprocal
expression betweenmiR-31 and SDHA in pariPSCs and full-
iPSCs led us to speculate that SDHA might be a regulatory
target for miR-31. MiR-31 transduction greatly suppressed
SDHA expression (Figure 3), and miR-31 and shRNA-
SDHA had similar roles in reducing mitochondrial activ-
ities. Importantly, miR-31 or shRNA-SDHA markedly
increased cell populations expressing TRA1-60, a marker
for ESCs and fully reprogrammed cells, when transduced
into CB-CD34+ cells (Figure 4F). Transduction of miR-31
or shRNA-SDHA in pariPSCs was not as apparent for
inducing TRA1-60 expression as seen in CB-CD34+ cells
(Figure 4F). This suggests that miR-31 should reside in cells
at early stages of reprogramming to efficiently improve
reprogramming. Early appearance of miR-31 (in this case
CB-CD34+ cells) may equip cells in a more favorable intra-
cellular environment to downmodulate mitochondrial
ETC activity and alter mitochondrial features such as ROS
generation, membrane potential, and mass.
It is unclear whether altered function of mitochondrial
metabolites actually mediates the effects of miR-31 and
shRNA-SDHA on increasing reprogramming efficiency.
We carried out experiments to trace glucose metabolites af-
ter transduction with miR-31 or shRNA-SDHA by using
13C-labeled glucose. Unfortunately, 13C radioactivity of
mitochondrial metabolites was too low to detect due to
the high content of glucose existing in reprogramming
culture medium. We evaluated whether changes in mito-
chondrial levels of succinate and fumarate, respective sub-
strates and products of SDHA, affected reprogramming effi-
ciency.While overexpression ofmiR-31 or shRNA-SDHA in
partially reprogrammed cells significantly increased succi-
nate levels, almost to that of fully reprogrammed iPSCs
(data not shown), this did not significantly change reprog-
ramming efficiency (data not shown). We tried to knock
down SDHB using shRNA to reveal the reprogramming ef-
fects of other subunits of the succinate dehydrogenase
complex. Because SDHA and SDHB compose hydrophilic
subunits of respiratory complex II in the inner mitochon-
drial membrane, we expected that SDHB might have the
potential to regulate reprogramming. However, we did
not see any effects of SDHB-shRNA. We suspect that
SDHB protein might have a slower turnover of translation
or that shRNA might not work strongly on the exact target
sequence of SDHB. Regardless, since transduction of8 Stem Cell Reports j Vol. 7 j 1–10 j July 12, 2016shRNA-SDHA resulted in attenuation of mitochondrial
functions, this most likely facilitates an environment
favorable for reprogramming.
Theoretically, enhanced induction of TRA1-60, a specific
marker for reprogrammed iPSCs by miR-31 and shRNA-
SDHA, can be achieved in two ways: improved reprogram-
ming efficiency or inhibiting pariPSCs from differentiating
back into somatic cells. We strongly favor the view that
enhanced induction of TRA1-60 by miR-31 and shRNA-
SDHA resulted from improved reprogramming efficiency.
Thus far, we have no evidence that pariPSCs differentiate
back into the original CD34+ cells they were derived
from, or any other type of somatic cells, in the presence
of Yamanaka factors.
Control of mitochondrial SDHA expression through
miR-31may be a way to increase reprogramming efficiency
at early reprogramming stages. This underlies the impor-
tance of SDHA and miR-31 for establishing a better under-
standing of miRNAmitochondria-related molecular mech-
anisms for reprogramming.EXPERIMENTAL PROCEDURES
All human studies were performed with the approval of an Institu-
tional Review Board from the Indiana University School of
Medicine (IUSM) (IRB No. 1011002987) and Konkuk University
Hospital (IRB No. KUH 1280081). All animal experiments were
performed in compliance with the Institutional Animal Care and
Use Committee of the IUSM (IACUC No. 10985 MD/R/E/AR) and
Konkuk University (IACUC No. KU15151-1) and the Guidelines
for the Care and Use of Laboratory Animals of the National
Research Council.
Complex II Activity
Complex II activity was assessed followingmanufacturer’s instruc-
tions (Abcam) (Grosso et al., 2013).
Respirometry
Respirometry analysis was performed with a Seahorse XF96 extra-
cellular flux analyzer as reported by Grosso et al. (2013).
Procedures for maintenance of hESC and hiPS, qRT-PCR for
miRNA, immunocytochemistry, western blotting, 30 UTR lucif-
erase reporter assays, teratoma assay, and flow cytometry analysis
have been reported by us previously (Lee et al., 2013). Full details
are provided in Supplemental Experimental Procedures.
Statistical Analysis
All experiments were performed three times in triplicate, and data
are represented as mean ± SD for statistical comparison. Signifi-
cance of differences was assessed by an unpaired t test at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.
05.012.
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